Development of T-cell lymphomas in Eμ-IEX-1 mice

Oncogene

Volumn 22, Issue 44, 2003, Pages 6845-6851

  Zhang, Yujin ^a,b   Finegold, Milton J ^a   Porteu, Françoise ^c   Kanteti, Prasad ^d   Wu, Mei X ^a,b,e  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^c INSTITUT COCHIN   (France)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Antiapoptosis; IEX 1; T cell lymphoma; Transgenic mice

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENHANCER REGION; GENE REARRANGEMENT; HISTOPATHOLOGY; IEX 1 GENE; IMMEDIATE EARLY GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; T CELL LYMPHOMA; T LYMPHOCYTE RECEPTOR GENE;

AGING; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; ANTIGENS, CD4; ANTIGENS, CD8; APOPTOSIS; B-LYMPHOCYTES; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION; GENE REARRANGEMENT, BETA-CHAIN T-CELL ANTIGEN RECEPTOR; GENES, IMMEDIATE-EARLY; LYMPHOMA, T-CELL; MICE; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SPLEEN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

ANIMALIA; DROMAIUS NOVAEHOLLANDIAE; MUS MUSCULUS;

EID: 0242574349     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206707     Document Type: Article

References (37)

1. Arlt A, Grobe O, Sieke A, Kruse ML, Folsch UR, Schmidt WE and Schafer H. (2001). Oncogene, 20, 69-76.
2. Ballif BA and Blenis J. (2001). Cell Growth Differ., 12, 397-408.
3. Charles CH, Yoon JK, Simske JS and Lau LF. (1993). Oncogene, 8, 797-801.
4. Chuang PI, Morefield S, Liu CY, Chen S, Harlan JM and Willerford DM. (2002). Blood, 99, 3350-3359.
5. Feldmann KA, Pittelkow MR, Roche PC, Kumar R and Grande JP. (2001). Histochem. Cell Biol., 115, 489-497.
6. Garcia J, Ye Y, Arranz V, Letourneux C, Pezeron G and Porteu F. (2002). EMBO J., 21, 5151-5163.
7. Ghebranious N and Donehower LA. (1998). Oncogene, 17, 3385-3400.
8. Grillot DA, Merino R and Nunez G. (1995). J. Exp. Med., 182, 1973-1983.
9. Grobe O, Arlt A, Ungefroren H, Krupp G, Folsch UR, Schmidt WE and Schafer H. (2001). FEBS Lett., 494, 196-200.
10. Huang YH, Wu JY, Zhang Y and Wu MX. (2002). Oncogene, 21, 6819-6828.
11. Im HJ, Pittelkow MR and Kumar R. (2002). J. Biol. Chem., 211, 14612-14621.
12. Jaattela M. (1999). Exp. Cell Res., 248, 30-43.
13. Katsumata M, Siegel RM, Louie DC, Miyashita T, Tsujimoto Y, Nowell PC, Greene MI and Reed JC. (1992). Proc. Natl. Acad. Sci. USA, 89, 11376-11380.
14. Kondratyev AD, Chung KN and Jung MO. (1996). Cancer Res., 56, 1498-1502.
15. Korsmeyer SJ. (1992). Blood, 80, 879-886.
16. Kumar R, Kobayashi T, Warner GM, Wu Y, Salisbury JL, Lingle W and Pittelkow MR. (1998). Biochem. Biophys. Res. Commun., 253, 336-341.
17. LaCasse EC, Baird S, Korneluk RG and MacKenzie AE. (1998). Oncogene, 17, 3247-3259.
18. Linette GP, Hess JL, Sentman CL and Korsmeyer SJ. (1995). Blood, 86, 1255-1260.
19. Malissen M, Minard K, Mjolsness S, Kronenberg M, Goverman J, Hunkapiller T, Prystowsky MB, Yoshikai Y, Fitch F, Mak TW and Hood L. (1984). Cell, 37, 1101-1110.
20. McDonnell TJ, Deane N, Platt FM, Nunez G, Jaeger U, McKearn JP and Korsmeyer SJ. (1989). Cell, 57, 79-88.
21. McDonnell TJ and Korsmeyer SJ. (1991). Nature, 349, 254-256.
22. Pezzella F, Gatter KC, Mason DY, Bastard C, Duval C, Krajewski A, Turner GE, Ross FM, Clark H and Jones DB. (1990). Lancet, 336, 1510-1511.
23. Pietzsch A, Buchler C, Aslanidis C and Schmitz G. (1997). Biochem. Biophys. Res. Commun., 235, 4-9.
24. Pietzsch A, Buchler C and Schmitz G. (1998). Biochem. Biophys. Res. Commun., 245, 651-657.
25. Pircher H, Burki K, Lang R, Hengartner H and Zinkernagel RM. (1989). Nature, 342, 559-561.
26. Rosenbaum H, Harris AW, Bath ML, McNeall J, Webb E, Adams JM and Cory S. (1990). EMBO J., 9, 897-905.
27. Schaeffer HJ and Weber MJ. (1999). Mol. Cell. Biol., 19, 2435-2444.
28. Schafer H, Diebel J, Arlt A, Trauzold A and Schmidt WE. (1998). FEBS Lett., 436, 139-143.
29. Schafer H, Lettau P, Trauzold A, Banasch M and Schmidt WE. (1999). Pancreas, 18, 378-384.
30. Schilling D, Pittelkow MR and Kumar R. (2001). Oncogene, 20, 7992-7997.
31. Seite P, Hillion J, d'Agay MF, Gaulard P, Cazals D, Badoux F, Berger R and Larsen CJ. (1993). Leukemia, 7, 410-417.
32. Strasser A, Harris AW and Cory S. (1993). Oncogene, 8, 1-9.
33. Van Parijs L, Refaeli Y, Abbas AK and Baltimore D. (1999). Immunity, 11, 763-770.
34. Wu MX, Ao Z, Prasad KV, Wu R and Schlossman SF. (1998). Science, 281, 998-1001.
35. Wu MX, Daley JF, Rasmussen RA and Schlossman SF. (1995). Proc. Natl. Acad. Sci. USA, 92, 1525-1529.
36. Zhang Y, Schlossman SF, Edwards RA, Ou CN, Gu J and Wu MX. (2002). Proc. Natl. Acad. Sci. USA, 99, 878-883.
37. Zhou P, Levy NB, Xie H, Qian L, Lee CY, Gascoyne RD and Craig RW. (2001). Blood, 97, 3902-3909.